Jeanette M. Pots
Nijmegen, GE, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Fully closed and automated enrichment of primary blood dendritic cells for cancer immunotherapy.
Journal: Methods in cell biology
Published: March 28, 2024
Translating the Manufacture of Immunotherapeutic PLGA Nanoparticles from Lab to Industrial Scale: Process Transfer and In Vitro Testing.
Journal: Pharmaceutics
Published: July 18, 2022
Prophylactic vaccines are potent activators of monocyte-derived dendritic cells and drive effective anti-tumor responses in melanoma patients at the cost of toxicity.
Journal: Cancer immunology, immunotherapy : CII
Published: September 24, 2015
Effective Clinical Responses in Metastatic Melanoma Patients after Vaccination with Primary Myeloid Dendritic Cells.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: September 09, 2015
Humoral and cellular immune responses after influenza vaccination in patients with postcancer fatigue.
Journal: Human vaccines & immunotherapeutics
Published: May 22, 2015
Intranodal vaccination with mRNA-optimized dendritic cells in metastatic melanoma patients.
Journal: Oncoimmunology
Published: January 14, 2015
Comparison of antibodies and carbohydrates to target vaccines to human dendritic cells via DC-SIGN.
Journal: Biomaterials
Published: November 21, 2011
Cytokine profiles in cyst fluids from ovarian tumors reflect immunosuppressive state of the tumor.
Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
Published: September 28, 2011
Showing 1-10 of 10
Last Updated: 09/26/2026